Jonathan E. Freeman - 15 Feb 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
Caitlin Kontulis, attorney-in-fact
Issuer symbol
PHIO
Transactions as of
15 Feb 2022
Net transactions value
$0
Form type
4
Filing time
16 Feb 2022, 19:08:38 UTC
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Award $0 +10,000 +96% $0.000000 20,364 15 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
F2 Includes shares of common stock underlying unvested restricted stock units.